Initiating INVEGA SUSTENNA®
Fully initiate INVEGA SUSTENNA® for schizophrenia in 7 days with 2 initiation
doses—with no oral supplementation1
- Both initiation doses must be given in the deltoid muscle
- For patients who have not taken oral paliperidone, oral risperidone, or injectable risperidone, establish tolerability first
- Previous oral antipsychotics can be discontinued at the time of initiation of treatment with INVEGA SUSTENNA®
- To avoid a missed dose, patients may be given the second initiation dose within a ±4-day flexible window
- Utilizing the dosing window to help avoid missed doses should be considered the exception rather than the rule
- After initiation, plasma levels will gradually decline over the next 30 days. Plan accordingly for your patient’s first maintenance dose
Maintaining
INVEGA SUSTENNA®
Administer the first monthly maintenance dose* 5 weeks after the first injection (regardless of when the second injection was administered)1
- To avoid a missed dose, monthly maintenance doses may be given within a ±7-day flexible window
- Utilizing the maintenance dosing window to help avoid missed doses should be considered the exception rather than the rule
*The recommended maintenance dose for the treatment of schizophrenia is 117 mg. Patients may benefit from flexible maintenance dosing options within the available strengths.
Administration notes1
- Each injection must be administered by a healthcare professional
- Select the appropriate needle size depending on the patient’s weight and injection location
- Shake the prefilled syringe for at least 10 seconds before administering
A few simple adjustments in communication and integration between treatment teams may also help your patients make a successful transition between care settings.
Download these actionable best practices to address 7 common challenges associated with the continuity of care.
Reference: 1. INVEGA SUSTENNA® [Prescribing Information]. Titusville, NJ: Janssen Pharmaceuticals, Inc.